Altamira Therapeutics Ltd. - stock earnings
CYTO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -6.6 million USD | 128631 USD |
| 2022Q2 | -3.7 million USD | 611499 USD |
| 2022Q1 | -3.7 million USD | 611499 USD |
| 2021Q4 | -5.3 million USD | 31941 USD |
| 2021Q3 | -5.3 million USD | 31941 USD |
| 2021Q2 | -3.4 million CHF | ? CHF |
| 2021Q1 | -3.4 million CHF | ? CHF |
| 2020Q4 | 7.4 million USD | 263831 USD |
| 2020Q2 | -1.4 million USD | ? USD |
| 2020Q1 | 7.0 million USD | -58343 USD |
| 2019Q4 | -6.8 million USD | ? USD |
| 2018Q4 | -3.8 million USD | 1.3 million USD |
| 2018Q3 | -3.1 million USD | ? USD |
| 2018Q2 | -3.1 million USD | ? USD |
| 2018Q1 | -1.8 million USD | ? USD |
| 2017Q4 | -4.7 million USD | 329053 USD |
| 2017Q3 | -6.2 million USD | ? USD |
| 2017Q2 | -5.7 million USD | ? USD |
| 2017Q1 | -8.4 million USD | ? USD |
| 2016Q4 | -5.3 million USD | -406758 USD |
| 2016Q3 | -8.2 million USD | ? USD |
| 2016Q2 | -8.6 million USD | ? USD |
| 2016Q1 | -9.2 million USD | ? USD |
| 2015Q4 | -5.6 million USD | -67812 USD |
| 2015Q3 | -5.4 million USD | ? USD |
| 2015Q2 | -11.8 million USD | ? USD |
| 2015Q1 | -8.3 million USD | ? USD |
| 2014Q4 | -4.0 million USD | 3.0 million USD |
| 2014Q3 | -3.5 million USD | ? USD |
| 2014Q2 | -5.6 million USD | ? USD |
| 2014Q1 | -6.6 million USD | ? USD |
| 2013Q4 | -3.9 million USD | ? USD |
| 2013Q3 | -4.9 million USD | ? USD |
| 2013Q2 | -5.1 million USD | ? USD |
| 2013Q1 | -2.3 million USD | ? USD |
CYTO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -28.7 million USD | 330548 USD |
| 2021 | -19.1 million USD | 70053 USD |
| 2020 | -9.1 million USD | 194228 USD |
| 2019 | -6.8 million USD | -57800 USD |
| 2018 | -11.7 million USD | 1.3 million USD |
| 2017 | -24.9 million USD | 329053 USD |
| 2016 | -30.1 million USD | -406758 USD |
| 2015 | -30.1 million USD | -67812 USD |
| 2014 | -18.4 million USD | 3.0 million USD |
| 2013 | -16.9 million USD | ? USD |
| 2012 | -5.0 million USD | ? USD |
CYTO
Price: $1.64
52 week price:
Earnings Per Share: -439.97 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 22400
Market Capitalization: 3.6 million